361 related articles for article (PubMed ID: 25542076)
21. Multiple functions of neuronal plasma membrane neurotransmitter transporters.
Raiteri L; Raiteri M
Prog Neurobiol; 2015 Nov; 134():1-16. PubMed ID: 26300320
[TBL] [Abstract][Full Text] [Related]
22. Human placental monoamine transporters as targets for amphetamines.
Ramamoorthy JD; Ramamoorthy S; Leibach FH; Ganapathy V
Am J Obstet Gynecol; 1995 Dec; 173(6):1782-7. PubMed ID: 8610762
[TBL] [Abstract][Full Text] [Related]
23. Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transporters.
Severinsen K; Kraft JF; Koldsø H; Vinberg KA; Rothman RB; Partilla JS; Wiborg O; Blough B; Schiøtt B; Sinning S
ACS Chem Neurosci; 2012 Sep; 3(9):693-705. PubMed ID: 23019496
[TBL] [Abstract][Full Text] [Related]
24. Application of a Combined Approach to Identify New Psychoactive Street Drugs and Decipher Their Mechanisms at Monoamine Transporters.
Mayer FP; Luf A; Nagy C; Holy M; Schmid R; Freissmuth M; Sitte HH
Curr Top Behav Neurosci; 2017; 32():333-350. PubMed ID: 28025810
[TBL] [Abstract][Full Text] [Related]
25. Dopamine neuronal transport kinetics and effects of amphetamine.
Jones SR; Joseph JD; Barak LS; Caron MG; Wightman RM
J Neurochem; 1999 Dec; 73(6):2406-14. PubMed ID: 10582600
[TBL] [Abstract][Full Text] [Related]
26. In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1.
Simmler LD; Buchy D; Chaboz S; Hoener MC; Liechti ME
J Pharmacol Exp Ther; 2016 Apr; 357(1):134-44. PubMed ID: 26791601
[TBL] [Abstract][Full Text] [Related]
27. Monoamine transporter pharmacology and mutant mice.
Gainetdinov RR; Sotnikova TD; Caron MG
Trends Pharmacol Sci; 2002 Aug; 23(8):367-73. PubMed ID: 12377578
[TBL] [Abstract][Full Text] [Related]
28. Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants.
Jayanthi LD; Ramamoorthy S
AAPS J; 2005 Oct; 7(3):E728-38. PubMed ID: 16353949
[TBL] [Abstract][Full Text] [Related]
29. Neurotransmitter transporters as molecular targets for addictive drugs.
Amara SG; Sonders MS
Drug Alcohol Depend; 1998; 51(1-2):87-96. PubMed ID: 9716932
[TBL] [Abstract][Full Text] [Related]
30. Substrate and inhibitor binding to the serotonin transporter: Insights from computational, crystallographic, and functional studies.
Zeppelin T; Ladefoged LK; Sinning S; Schiøtt B
Neuropharmacology; 2019 Dec; 161():107548. PubMed ID: 30807752
[TBL] [Abstract][Full Text] [Related]
31. Psychoactive Bath Salts and Neurotoxicity Risk.
Altun B; Çok İ
Turk J Pharm Sci; 2020 Apr; 17(2):235-241. PubMed ID: 32454785
[TBL] [Abstract][Full Text] [Related]
32. 5-hydroxytryptamine metabolism in the brain under the influence of psychotropic drugs.
Herman ZS
Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):25-43. PubMed ID: 128747
[No Abstract] [Full Text] [Related]
33. Neurotransmitter transporters and their impact on the development of psychopharmacology.
Iversen L
Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S82-8. PubMed ID: 16402124
[TBL] [Abstract][Full Text] [Related]
34. [Pharmacology of monoamine neurotransmitter transporters].
Dohi T; Kitayama S; Kumagai K; Hashimoto W; Morita K
Nihon Yakurigaku Zasshi; 2002 Nov; 120(5):315-26. PubMed ID: 12491807
[TBL] [Abstract][Full Text] [Related]
35. A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.
Gold LH; Hubner CB; Koob GF
Psychopharmacology (Berl); 1989; 99(1):40-7. PubMed ID: 2571175
[TBL] [Abstract][Full Text] [Related]
36. The vesicular monoamine transporter: from chromaffin granule to brain.
Henry JP; Sagné C; Bedet C; Gasnier B
Neurochem Int; 1998 Mar; 32(3):227-46. PubMed ID: 9587917
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular and temperature adverse actions of stimulants.
Docherty JR; Alsufyani HA
Br J Pharmacol; 2021 Jul; 178(13):2551-2568. PubMed ID: 33786822
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse.
Crooks PA; Zheng G; Vartak AP; Culver JP; Zheng F; Horton DB; Dwoskin LP
Curr Top Med Chem; 2011; 11(9):1103-27. PubMed ID: 21050177
[TBL] [Abstract][Full Text] [Related]
39. Interaction of amphetamines and related compounds at the vesicular monoamine transporter.
Partilla JS; Dempsey AG; Nagpal AS; Blough BE; Baumann MH; Rothman RB
J Pharmacol Exp Ther; 2006 Oct; 319(1):237-46. PubMed ID: 16835371
[TBL] [Abstract][Full Text] [Related]
40. New Psychoactive Substances: Chemistry, Pharmacology, Metabolism, and Detectability of Amphetamine Derivatives With Modified Ring Systems.
Welter-Luedeke J; Maurer HH
Ther Drug Monit; 2016 Feb; 38(1):4-11. PubMed ID: 26327309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
